A multicenter, double-blind, randomized, placebo-controlled study of rifaximin for the treatment of bacterial vaginosis

International Journal of Gynecology and Obstetrics

Volumn 120, Issue 2, 2013, Pages 131-136

  Donders, Gilbert G G ^a   Guaschino, Secondo ^b   Peters, Klaus ^c   Tacchi, Raffaella ^d   Lauro, Vittoria ^d  

^a Heilig Hart Tienen ^*  (Belgium)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^c ALBERTINEN KRANKENHAUS   (Germany)

^d Alfa Wassermann SpA   (Italy)

Author keywords

Bacterial vaginosis; Efficacy; Placebo; Randomized; Recurrence; Rifaximin

Indexed keywords

PLACEBO; RIFAXIMIN;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VAGINA PAIN; VAGINAL BURNING SENSATION; VAGINAL PRURITUS; VAGINITIS; VULVOVAGINAL DISCOMFORT;

EID: 84872812868     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2012.08.022     Document Type: Article

References (25)

1. E.H. Koumans, M. Sternberg, C. Bruce, G. McQuillan, J. Kendrick, and M. Sutton The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health Sex Transm Dis 34 11 2007 864 869
2. G.G. Donders Definition and classification of abnormal vaginal flora Best Pract Res Clin Obstet Gynecol 21 3 2007 355 373
3. D.N. Fredricks, T.L. Fiedler, and J.M. Marrazzo Molecular identification of bacteria associated with bacterial vaginosis N Engl J Med 353 18 2005 1899 1911
4. B.B. Oakley, T.L. Fiedler, J.M. Marrazzo, and D.N. Fredricks Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis Appl Environ Microbiol 74 15 2008 4898 4909
5. Z. Ling, J. Kong, F. Liu, H. Zhu, X. Chen, and Y. Wang Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis BMC Genomics 11 2010 488
6. J. Atashili, C. Poole, P.M. Ndumbe, A.A. Adimora, and J.S. Smith Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies AIDS 22 12 2008 1493 1501
7. G.G. Donders, B. Van Bulck, J. Caudron, L. Londers, A. Vereecken, and B. Spitz Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion Am J Obstet Gynecol 183 2 2000 431 437
8. A.H. Ugwumadu Bacterial vaginosis in pregnancy Curr Opin Obstet Gynecol 14 2 2002 115 118
9. H. Leitich, B. Bodner-Adler, M. Brunbauer, A. Kaider, C. Egarter, and P. Husslein Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis Am J Obstet Gynecol 189 1 2003 139 147
10. O.O. Oduyebo, R.I. Anorlu, and F.T. Ogunsola The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women Cochrane Database Syst Rev 3 2009 CD006055
11. C.S. Bradshaw, A.N. Morton, J. Hocking, S.M. Garland, M.B. Morris, and L.M. Moss High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence J Infect Dis 193 11 2006 1478 1486
12. J. Paavonen, C. Mangioni, M.A. Martin, and C.P. Wajszczuk Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial Obstet Gynecol 96 2 2000 256 260
13. J.Y. Chen, H. Tian, and R.H. Beigi Treatment considerations for bacterial vaginosis and the risk of recurrence J Womens Health (Larchmt) 18 12 2009 1997 2004
14. D.N. Gerding Clostridium difficile 30 years on: what has, or has not, changed and why? Int J Antimicrob Agents 33 Suppl. 1 2009 S2 S8
15. C. Scarpignato, and I. Pelosini Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential Chemotherapy 51 Suppl. 1 2005 36 66
16. I. Pelosini, and C. Scarpignato Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tract Chemotherapy 51 Suppl. 1 2005 122 130
17. R. Amsel, P.A. Totten, C.A. Spiegel, K.C. Chen, D. Eschenbach, and K.K. Holmes Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations Am J Med 74 1 1983 14 22
18. R.P. Nugent, M.A. Krohn, and S.L. Hillier Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation J Clin Microbiol 29 2 1991 297 301
19. E.E. Petersen, M. Genet, M. Caserini, and R. Palmieri Efficacy of vitamin C vaginal tablets in the treatment of bacterial vaginosis: a randomised, double blind, placebo controlled clinical trial Arzneimittelforschung 61 4 2011 260 265
20. P. Nyirjesy, M.J. McIntosh, D.J. Gattermeir, R.J. Schumacher, J.I. Steinmetz, and J.L. Joffrion The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis Am J Obstet Gynecol 194 5 2006 1277 1282
21. M.J. Ferris, A. Masztal, K.E. Aldridge, J.D. Fortenberry, P.L. Fidel Jr., and D.H. Martin Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis BMC Infect Dis 4 2004 5
22. A. Swidsinski, W. Mendling, V. Loening-Baucke, S. Swidsinski, Y. Dörffel, and J. Scholze An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole Am J Obstet Gynecol 198 1 2008 97.e1 97.e6
23. G. Donders Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review Obstet Gynecol Surv 65 7 2010 462 473
24. US Department of Health and Human Services, Food and Drug Administration, and Center for Drug Evaluation and Research (CDER) Guidance for Industry Bacterial Vaginosis - Developing Antimicrobial Drugs for Treatment http://www.fda.gov/downloads/Drugs/./Guidances/ucm070969.pdf [Published July 1998]
25. K.K. Thomas, S. Sanchez, P.J. Garcia, and K.K. Holmes Why do different criteria for "cure" yield different conclusions in comparing two treatments for bacterial vaginosis? Sex Transm Dis 32 9 2005 526 530